ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 126

Asymptomatic Versus Symptomatic Ankle Joints in Rheumatoid Arthritis: A High Resolution B-Mode and Power Doppler Ultrasound Study

Mohammed Alsuwaidi1, Boris P. Ehrenstein1, Wolfgang Hartung1 and Martin Fleck2, 1Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, 2Internal Medicine I, University Medical Center of Regensburg, Regensburg, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Imaging, Rheumatoid arthritis (RA), ultrasonography and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose: Despite a crucial role for RA patients’ mobility, the ankle joints are frequently clinically neglected, and omitted in activity scoring systems including DAS 28. In addition, only few studies have assessed pathologies detected by ultrasonography of the ankle in symptomatic RA patients (1). Therefore, the type and degree of involvement of the ankle joints were evaluated in established RA patients regardless of symptomatology utilizing standardized high resolution musculoskeletal ultrasound (MSUS) including power Doppler ultrasonography (PDUS). 

Methods: A total number of 160 ankle joints of 80 consecutive RA patients fulfilling the ACR/EULAR classification criteria 2010 were examined using MSUS (Logic E9, GE Healthcare, Buckinghamshire, GB with a ML6-15 linear probe with 6- 15 MHz) and PDUS according to the EULAR MSUS guidelines (2). In addition, the talonavicular joint, and the flexor and extensor tendons were investigated. Furthermore, ankle pain (VAS score 0-10) was recorded for each patient on joint level. Only VAS = 0 was determined as asymptomatic.

Results: 80 RA patients (52 female, 28 male) with a median age of 60 years (range 28 -81) and a disease duration of 5 years (range 0 – 44) were enrolled in our study. The median DAS28 was 5,0 (range 0,8 -7,8). 97 ankles were painfull (VAS 1-10), whereas 63 ankles were asymptomatic (VAS = 0). Overall, the predominant pathology was arthritis of the tibiotalar and/or talonavicular joint in 124 ankles (77%), followed by tenosynovitis of the flexor tendons in 44 ankles (28%). In symptomatic ankles 59% showed arthritis of the tibiotalar joint (TTJ) and 35% synovitis in the talonavicular joint (TNJ). In 35% of the asymptomatic ankles TTJ synovitis could be detected and 18% TNJ arthritis. PDUS activity was higher in the subgroup of symptomatic ankles (10% of symptomatic ankles (10/97) compared to 2% of asymptomatic patients (3/63). For detailed information see table 1.

Conclusion: Most frequent pathologies detected by MSUS were arthritis of the tibiotalar and talonavicular joint, followed by tenosynovitis of the flexor tendons. Pathologic findings are significantly more frequent in symptomatic ankles but also common in completely asymptomatic ankles of RA patients, whereas overall PDUS activity is low and if present predominately observed in symptomatic patients.

Table 1:

          Pathologies

            

Arthritis

tibiotalar (%)

 

Arthritis talonavicular

Tenosynovitis

(M. tibialis posterior +/ or M. flexor digitorum)

PDUS positive

Arthritis

All ankles (n = 160)

79 (66%)

45 (28%)

44 (27%)

12 (7,5%)

Symptomatic ankles

(n=97)

57 (59%)

34 (35%)

32 (33%)

10 (10%)

Asymptomatic ankles (n=63)

22 (35%)

11 (18%)

12 (19%)

2 (3%)

Chi2

p = 0.003

p = 0.016

n.s.

n.s.

References:

1Suzuki T, Okamoto A, Clin Exp Rheumatol 2013, 31 (2): 281-284. 2Backhaus M, Burmester G-R, Gerber T et al., Ann Rheum Dis 2001, 60:

641-649


Disclosure:

M. Alsuwaidi,
None;

B. P. Ehrenstein,
None;

W. Hartung,
None;

M. Fleck,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/asymptomatic-versus-symptomatic-ankle-joints-in-rheumatoid-arthritis-a-high-resolution-b-mode-and-power-doppler-ultrasound-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology